Core Insights - The company achieved a revenue of 1.495 billion yuan in the first half of 2025, representing a year-on-year growth of 9.5% [1] - The gross profit reached 458 million yuan, with a growth of 14.1%, and the net profit was 152 million yuan, increasing by 41.6% [1] - The gross margin improved to 30.63%, up by 1.24 percentage points [1] Business Performance - The revenue from healthcare solutions was 1.485 billion yuan, growing by 10.4%, primarily due to the growth in offline medical institutions [2] - Revenue from medical health products was 10 million yuan, declining by 50.9%, as the company strategically focused on healthcare solutions [2] - Offline medical institution revenue was 1.467 billion yuan, up by 11.1%, while online healthcare platform revenue was 127 million yuan, down by 5.2% [2] - The company acquired 452,600 new clients, a growth of 7.77%, with a total of 250 million client visits, increasing by 29.53% [2] - The client retention rate was 69.3%, and member visits totaled 1.08 million, growing by 15.14%, with a member retention rate of 85% [2] Strategic Developments - The company launched its first national AI medical avatar in June 2025, with a total of 10 AI avatars covering eight core specialties by August [3] - In the first half of 2025, the company added five offline medical institutions and acquired several entities, bringing the total to 83 medical institutions in China and one in Singapore [3] - The company received traditional Chinese medicine preparation licenses for its internal preparation center, which has completed construction and trial production [3]
固生堂(02273.HK)：2025上半年业绩稳健增长 盈利能力持续提升